| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.047 | 0.4 |